I. Levenbook

发表

Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.

E. Dragunsky, I. Levenbook, Y. Pervikovc, 2000, Vaccine.

RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence

K. Chumakov, E. Dragunsky, I. Levenbook, 1992, Journal of virology.

Effects of γ-IFN and NGF on subpopulations in a human neuroblastoma cell line: Flow cytometric and morphological analysis

I. Levenbook, D. Terle, J. Ridge, 1996, In Vitro Cellular & Developmental Biology - Animal.

Pharmacokinetic studies of mouse monoclonal antibodies to a rat colon carcinoma: I. Comparison of biodistribution in normal rats, syngeneic tumor-bearing rats, or tumor-bearing nude mice.

J. Douillard, J. Laborda, I. Levenbook, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tumorigenicity of Vero cells.

I. Levenbook, B. Elisberg, J. Petricciani, 1984, Journal of biological standardization.

Experimental evaluation of antitoxic protective effect of new cholera vaccines in mice.

H. D. Hochstein, E. Dragunsky, I. Levenbook, 1992, Vaccine.

Early passage primate cell immortality is independent of tumorigenicity

I. Levenbook, J. Petricciani, D. Wierenga, 1987, In Vitro Cellular & Developmental Biology.

Human muscle: a model for the study of human neoplasia

I. Levenbook, J. Petricciani, Robert B. Locke, 2004, Investigational New Drugs.

Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.

Z. Lu, K. Chumakov, E. Dragunsky, 1995, Virology.

Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine.

Z. Lu, K. Chumakov, E. Dragunsky, 1994, Virology.

A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.

T. Nomura, E. Dragunsky, K. Hioki, 1996, Biologicals : journal of the International Association of Biological Standardization.

Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys

A. Barrett, F. Guirakhoo, T. Monath, 2000, Journal of Virology.

Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors.

J. Douillard, J. Laborda, I. Levenbook, 1989, Cancer research.

The role of non-human primates in the neurological safety of live viral vaccines (review).

I. Levenbook, 2011, Biologicals : journal of the International Association of Biological Standardization.

Tumorigenicity testing of primate cell lines in nude mice, muscle organ culture and for colony formation in soft agarose.

I. Levenbook, B. Elisberg, J. Petricciani, 1985, Journal of biological standardization.

Comparison of the colony forming ability and invasive potential of six primate cell lines treated with retinoic acid

I. Levenbook, T. Saiga, J. Petricciani, 2004, Investigational New Drugs.

Characteristics of seven clones of the WiDr human colon adenocarcinoma cell line

P. Noguchi, I. Levenbook, E. M. Earley, 1982, In Vitro.

Neuropathogenesis and Neurovirulence of Live Flaviviral Vaccines in Monkeys

I. Levenbook, K. Draper, 2009, Journal of Virology.

Rhesus diploid rabies vaccine (adsorbed): neurological safety in guinea pigs and Lewis rats.

I. Levenbook, B. Driscoll, B. Elisberg, 1986, Vaccine.

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

A. Barrett, F. Guirakhoo, T. Monath, 1999, Vaccine.

Monkey neurovirulence test for live mumps vaccine.

P. Snoy, O. Maximova, E. Dragunsky, 1996, Biologicals : journal of the International Association of Biological Standardization.

The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination.

I. Levenbook, B. Elisberg, L. Pelleu, 1987, Journal of biological standardization.

Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.

I. Roninson, K. Chumakov, I. Levenbook, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines

Ken Draper, F. Guirakhoo, T. Monath, 2002, Journal of Virology.

Propagation and properties of Kaposi's sarcoma-derived cell lines obtained from patients with AIDS: similarity of cultured cells to smooth muscle cells.

A. Albini, G. Martin, I. Levenbook, 1991, AIDS.

A comparison of three routes of inoculation for testing tumorigenicity of cell lines in nude mice.

I. Levenbook, J. Petricciani, P. Smith, 1981, Journal of biological standardization.

Morphology of tumors induced in Hamsters by Simian adenoviruses

I. Levenbook, A. Altstein, A. E. Chigirinsky, 1968, International journal of cancer.

Large‐ and small‐plaque variants of oncogenic simian adenovirus SA7(C8)

I. Levenbook, A. Altstein, N. N. Dodonova, 1969, International journal of cancer.

Morphology of tumors induced in hamster soft tissues by bovine adenovirus type 3

I. Levenbook, N. M. Strizhachenko, 1971, International journal of cancer.

Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

F. Guirakhoo, T. Monath, J. Lang, 2004, Journal of Virology.

A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys

F. Guirakhoo, T. Monath, J. Lang, 2004, Journal of Virology.

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.

F. Guirakhoo, T. Monath, R. A. Beck, 2005, Biologicals : journal of the International Association of Biological Standardization.

In vitro characterization of Salmonella typhi mutant strains for live oral vaccines.

H. D. Hochstein, E. Dragunsky, I. Levenbook, 1990, Vaccine.

Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.

K. Chumakov, E. Dragunsky, G. Rezapkin, 1995, Virology.

Limited genetic changes in the Sabin 1 strain of poliovirus occurring in the central nervous system of monkeys.

K. Chumakov, G. Rezapkin, I. Levenbook, 1996, The Journal of general virology.

Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.

E. Dragunsky, I. Levenbook, R. Taffs, 1993, Biologicals : journal of the International Association of Biological Standardization.

Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge.

E. Dragunsky, I. Levenbook, Y. Chernokhvostova, 1997, The Journal of infectious diseases.

Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.

Takeshi Kurata, Tatsuji Nomura, A. Heath, 2003, Bulletin of the World Health Organization.

Salmonella typhi vaccine strain in vitro; low infectivity in human cell line U937.

E. Dragunsky, I. Levenbook, S. Vargo, 1989, Journal of biological standardization.